Outcome of patients with fortuitous prostate cancer after radical cystoprostatectomy for bladder cancer

European Urology

Volumn 48, Issue 6, 2005, Pages 946-950

  Delongchamps, Nicolas Barry ^a   Mao, Kaili ^a   Theng, Hang ^a   Zerbib, Marc ^a   Debré, Bernard ^a   Peyromaure, Michaël ^a  

^a Service d'Urologie ^*  (France)

Author keywords

Bladder tumour; Cystoprostatectomy; Diagnosis; Prostate cancer

Indexed keywords

CISPLATIN; DOXORUBICIN; METHOTREXATE; VINBLASTINE;

ADULT; AGED; BLADDER CARCINOMA; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CYSTECTOMY; EXPERIENCE; FOLLOW UP; HUMAN; HUMAN TISSUE; MALE; MEDICAL RECORD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RECURRENT CANCER; RETROSPECTIVE STUDY; REVIEW; SCORING SYSTEM; TISSUE SECTION; TREATMENT OUTCOME;

EID: 27844533652     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2005.07.008     Document Type: Article

References (22)

1. H.S. Evans, and H. Moller Recent trends in prostate cancer incidence and mortality in southeast England Eur Urol 43 2003 337 341
2. A. Majeed, P. Babb, J. Jones, and M. Quinn Trends in prostate cancer incidence, mortality and survival in England and Whales 1971-1978 BJU Int 85 2000 1058 1062
3. B. Holund Latent prostatic cancer in a consecutive autopsy series Scand J Urol Nephrol 14 1980 29 35
4. S.H. Landis, T. Murray, S. Bolden, and P.A. Wingo Cancer statistics CA Cancer J Clin 49 1999 8 31 [comment]
5. T.Y. Chun Coincidence of bladder and prostate cancer J Urol 157 1997 65 67
6. F. Abbas, D. Hochberg, F. Civantos, and M. Soloway Incidental Prostatic Adenocarcinoma in Patients Undergoing Radical Cystoprostatectomy for Bladder Cancer Eur Urol 30 1996 322 326
7. A. Konski, P. Rubin, P.A. Disantangnese, E. Mayer, and H. Keys Simultaneous presentation of adenocarcinoma of prostate and transitional cell carcinoma of bladder Urology 37 1991 202 206
8. K. Kurokawa, K. Ito, and T. Yamamoto Comparative study on the prevalence of clinically detectable prostate cancer in patients with and without bladder cancer Urology 63 2004 268 272
9. A. Singh, Y. Kinoshita, and P.M. Rovito Higher than expected association of clinical prostate and bladder cancers J Urol 173 2005 1526 1529
10. A. Singh, R.F. Jones, and H. Friedman Expression of P53 and pRb in bladder and prostate cancer of patients having both cancers Anticancer Res 19 1999 5415 5417
11. N. Amara, G.S. Palapattu, and M. Schrage Prostate stem cell antigen is overexpressed on human transitional cell carcinoma Cancer Res 61 2001 4660 4665
12. H.N. Winfield, P.K. Reddy, and P.H. Lange Coexisting Adenocarcinoma of Prostate in Patients undergoing cystoprostatectomy for bladder cancer Urology 30 1987 100 101
13. T.R. Pritchett, J. Moreno, and N.E. Warner Unsuspected prostatic adenocarcinoma in patients who have undergone radical cystoprostatectomy for transitionnal cell carcinoma of the bladder J Urol 139 1988 1214 1216
14. J.N. Kabalin, J.F. McNeal, H.M. Price, F.S. Freiha, and T.A. Stamey Unsuspected adenocarcinoma of the prostate in patients undergoing cystoprostatectomy for other causes: incidence, histology and morphometric observations J Urol 141 1989 1091 1094
15. J.E. Montie, D.P. Wood Jr., J.E. Pontes, J.M. Boyett, and H.S. Levin Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer Cancer 63 1989 381 385
16. G. Moutzouris, C. Barbatis, and D. Plastiras Incidence and Histological Findings of Unsuspected Prostatic Adenocarcinoma in Radical Cystoprostatectomy for Transitional Cell Carcinoma of the Bladder Scand J Urol Nephrol 33 1999 27 30
17. W. Prange, A. Erbersdobler, and P. Hammerer High-grade prostatic intraepithelial neoplasia in cystoprostatectomy specimens Eur Urol 39 2001 30 31
18. J.F. Ward, G. Bartsch, T.J. Sebo, G.M. Pinggera, M.L. Blute, and H. Zincke Pathologic characterization of prostate cancers with a very low serum prostate specific antigen (0-2 ng/mL) incidental to cystoprostatectomy: is PSA a useful indicator of clinical significance? Urol Oncol 22 2004 40 47
19. M.P. Revelo, M.S. Cookson, S.S. Chang, M.S. Shook, J.A. Smith, and S.B. Shappell Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery J Urol 171 2004 646 651
20. P.A. Androulakakis, H.M. Schneider, G.H. Jacobi, and R. Hohenfellner Coincident vesical transitional cell carcinoma and prostatic carcinoma. Clinical features and treatment Br J Urol 58 1986 153 156
21. C. Terrone, C. Cracco, R.M. Scarpa, and S.R. Rossetti Supra-ampullar cystectomy with preservation of sexual function and ileal orthotopic reservoir for bladder tumor: twenty years of experience Eur Urol 46 2004 264 269
22. H. Botto, P. Sebe, V. Molinie, J.M. Herve, L. Yonneau, and T. Lebret Prostatic capsule- and seminal-sparing cystectomy for bladder carcinoma: initial results for selected patients BJU Int 94 2004 1021 1025